Quarterly Report • May 13, 2016
Quarterly Report
Open in ViewerOpens in native device viewer
KSG Agro S.A.
Unaudited Interim Condensed Consolidated Financial Statements
31 March 2016
| Unaudited Interim Condensed Consolidated Statement of Financial Position……………………………………… | 1 |
|---|---|
| Unaudited Interim Condensed Consolidated Income Statement………………………………………………………… | 2 |
| Unaudited Interim Condensed Consolidated Statement of Other Comprehensive Income…………………………2 | |
| Unaudited Interim Condensed Consolidated Statement of Cash Flows 3 | |
| Unaudited Interim Condensed Consolidated Statement of Changes in Equity | 5 |
Notes to the Unaudited Interim Condensed Consolidated Financial Statements
| 1. | Background……………………………………………………………………………………………………………….6 | |
|---|---|---|
| 2. | Summary of significant accounting policies……………………………………………………………….……7 | |
| 3. | Critical accounting estimates and judgements in applying accounting policies 13 | |
| 4. | Businesses' disposals and disposal groups 15 | |
| 5. | Property, plant and equipment 15 | |
| 6. | Intangible assets 15 | |
| 7. | Inventories and agricultural produce 16 | |
| 8. | Current biological assets 16 | |
| 9. | Trade and other accounts receivable 17 | |
| 10. | Loans and borrowings 17 | |
| 11. | Trade and other accounts payable 18 | |
| 12. | Revenue 18 | |
| 13. | Cost of sales 18 | |
| 14. | Selling, general and administrative expenses 18 | |
| 15. | Other income/ (expenses), net ………………………………………………………………………………….….19 | |
| 16. | Finance income and expenses .19 | |
| 17. | Foreign exchange impact……………………………………………………………………………………………20 | |
| 18. | Operating segments……………………………………………………………………………………………….…20 | |
| 19. | Related parties 22 | |
| 20. | Subsequent events 22 |
| Unaudited Interim Condensed Consolidated Statement of Financial Positior | ||||
|---|---|---|---|---|
| --------------------------------------------------------------------------------- | -- | -- | -- | -- |
| In thousands of US dollars | Note | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|---|
| ASSETS | |||
| Non-current assets | |||
| Property, plant and equipment | 5 | ||
| Intangible assets | 6 | 20,939 | 22,500 |
| Long-term biological assets | 485 | 570 | |
| 15,591 | 16,631 | ||
| Long-term receivables | 902 | 926 | |
| Deferred expense | 1,024 | 1,025 | |
| Deferred tax assets | 107 | 117 | |
| Promissory notes receivable | 208 | 217 | |
| Term deposits | 1,591 | 1,738 | |
| Total non-current assets | 40,847 | 43,724 | |
| Current assets | |||
| Current biological assets | |||
| Inventories and agricultural produce | 8 | 4,323 | 4,118 |
| Trade and other accounts receivable | 7 | 3,533 | 3,759 |
| 9 | 6,712 | 10,952 | |
| Deferred expense | |||
| Taxes recoverable and prepaid | 579 | 554 | |
| Income tax prepaid | |||
| Term deposits | |||
| Cash and cash equivalents | 776 | 1,147 | |
| Total current assets | 15,923 | 20,530 | |
| TOTAL ASSETS | 56,770 | 64,254 | |
| EQUITY | |||
| Share capital | 150 | 150 | |
| Share premium | 37,366 | ||
| Treasury shares | (112) | 37,366 | |
| Retained earnings | (42, 624) | (112) | |
| Currency translation reserve | (41, 551) | ||
| Equity attributable to the owners of the Company | (10, 239) | (9,616) | |
| Non-controlling interests | (15, 459) | (13, 763) | |
| 6,188 | 5,863 | ||
| TOTAL EQUITY | (9,271) | (7,900) | |
| LIABILITIES | |||
| Non-current liabilities | |||
| Loans and borrowings | 10 | 37,316 | 39,486 |
| Promissory notes issued | 1,289 | 1,988 | |
| Deferred tax liability | |||
| Total non-current liabilities | 38,605 | 41,474 | |
| Current liabilities | |||
| Loans and borrowings | 10 | ||
| Trade and other accounts payable | 11 | 8,966 | 7,388 |
| Share purchase warrant | 18,015 | 22,864 | |
| Promissory notes issued | |||
| 336 | 268 | ||
| Taxes payable | 119 | 160 | |
| Income tax payable | |||
| Total current liabilities | 27,436 | 30,680 | |
| TOTAL LIABILITIES | 66,041 | 72,154 | |
| TOTAL LIABILITIES AND EQUITY | 56 770 | GA OFA |
| Note | Three months ended 31 March 2016 |
2015 | |
|---|---|---|---|
| In thousands of US dollars | (unaudited) | (unaudited) | |
| Revenue | 12 | 4,658 | 2,430 |
| Gain on initial recognition at fair value and net change in fair value | |||
| of biological assets less estimated point-of-sale costs Cost of sales |
13 | 208 (3,601) |
(468) (2,670) |
| Gross profit/(loss) | 1,265 | (708) | |
| Government grant received | 2 | 116 | |
| Selling, general and administrative expenses | 14 | (125) | (333) |
| Other operating income | - | 14 | |
| Other operating expenses | - | (71) | |
| Operating (loss)/profit | 1,142 | (982) | |
| Finance income | 16 | 222 | 413 |
| Finance expenses | 16 | (1,085) | (1,122) |
| Foreign currency exchange gain/(loss), net | 17 | (1,834) | (8,143) |
| Other income | 15 | - | 454 |
| Other expenses Loss before tax |
15 | (208) (1,763) |
(352) (9,732) |
| Income tax benefit/(expense) | (2) | (1) | |
| Loss for the year | (1,765) | (9,733) | |
| (Loss)/Profit attributable to: | |||
| Owners of the Company | (1,073) | (8,342) | |
| Non-controlling interest | (692) | (1,391) | |
| Loss for the year | (1,765) | (9,733) | |
| Earnings per share | |||
| Weighted-average number of common shares outstanding | 15,020,000 | 15,020,000 | |
| Basic earnings per share, USD | (0.07) | (0.65) | |
| Diluted earnings per share, USD | (0.07) | (0.65) |
| In thousands of US dollars | Three months ended 31 March 2016 (unaudited) |
2015 (unaudited) |
|---|---|---|
| Profit / (loss) for the period | (1,765) | (9,733) |
| Other comprehensive income, net of income tax Currency translation differences |
394 | (3,549) |
| Total comprehensive income for the period | (1,371) | (13,282) |
| Total comprehensive income attributable to | ||
| Owners of the Company Non-controlling interests |
(1,696) 325 |
(8,622) (4,660) |
| Total comprehensive income for the period | (1,371) | (13,282) |
The accompanying notes are an integral part of these interim condensed consolidated financial statements
| Note | Three months ended 31 March | ||
|---|---|---|---|
| In thousands of US dollars | 2016 (unaudited) |
2015 (unaudited) |
|
| Cash flows from operating activities | |||
| Loss before tax | (1,763) | (9,732) | |
| Adjustments for: | |||
| Depreciation and amortization | 5,6 | 372 | 1,032 |
| Impairment and write-off of trade and other accounts receivable | 15 | - | 48 |
| Impairment of LLR | - | - | |
| Write-off TAR (Crimea) and prepayments | - | - | |
| Impairment of VAT receivable | - | 43 | |
| Reversal of impairment of provision for inventory | - | - | |
| Provision for inventory | - | 98 | |
| Unrealised gain on biological assets and agricultural produce | (208) | 468 | |
| Loss from dead crops | 15 | - | - |
| Exchange differences | 17 | 1,834 | 8,143 |
| Gain on share purchase warrant | - | - | |
| Loss on disposal of property, plant and equipment | 15 | - | (454) |
| Finance expenses other than share purchase warrant | 16 | 1,085 | 1,122 |
| Finance income | 16 | (143) | (86) |
| Gain/(loss) on subsidiaries disposal | - | - | |
| Loss on fines and penalties | - | - | |
| Goodwill impairment | - | - | |
| Unwinding of discount | 16 | (79) | (327) |
| Amortization of financial instruments | 16 | - | - |
| Other | - | ||
| Operating cash flows before working capital changes | 1,098 | 355 | |
| Change in trade and other accounts receivable | 3,320 | (5,777) | |
| Change in current biological assets | (744) | (799) | |
| Change in inventories and agricultural produce | (92) | 29 | |
| Change in trade and other accounts payable | (3,604) | 6,788 | |
| Cash generated from operations | (22) | 596 | |
| Interest paid | (436) | (209) | |
| Income tax paid | (42) | (11) | |
| Cash generated from / (used in) operating activities | (500) | 376 | |
| Cash flow from investment activities | |||
| Acquisition of property, plant and equipment | - | - | |
| Proceeds from disposal of property, plant and equipment | - | - | |
| Interest paid | - | - | |
| Disposal of subsidiaries/(assets held for sale), net of cash disposed | - | - | |
| Acquisition of subsidiaries, net of cash acquired | - | - | |
| Loan given | - | - | |
| Interest received | 143 | 86 | |
| Term deposit received/(placed) | - | - | |
| Investment payments | (56) | (138) | |
| Settlement of accounts payable related to investment activities | (23) | - | |
| Disposal of assets held for sale | - | - | |
| Net cash generated from / (used in) investment activities | 64 | (52) | |
| Three months ended 31 March 2016 2015 |
||||
|---|---|---|---|---|
| In thousands of US dollars | Note | (unaudited) (unaudited) | ||
| Cash flow from financing activities | ||||
| Proceeds from bank loans and other borrowings | - | - | ||
| Repayment of bank loans | - | (8) | ||
| Contributions to share capital | - | - | ||
| Reorganisation of interests | - | - | ||
| PN settlement | - | - | ||
| Repayment of financial lease liabilities | (14) | (16) | ||
| Net cash (used in) / received from financing activities | (14) | (24) | ||
| Net (decrease)/increase in cash and cash equivalents | (450) | 300 | ||
| Cash and cash equivalents at the beginning of the year | 1,147 | (147) | ||
| Effect of exchange rate differences on cash and cash equivalents | 79 | (28) | ||
| Cash and cash equivalents at the end of the year | 776 | 125 |
| Attributable to owners of the Company | Non | Total equity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| In thousands of US dollars | Share capital |
Share premium |
Treasury shares |
Prepayment for future share issue |
Currency translation reserve |
Retained earnings |
Total attributable to owners of the Company |
controlling interest |
|
| Balance as at 31 December 2015 (unaudited) |
150 | 37,366 | (112) | - | (9,616) | (41,551) | (13,763) | 5,863 | (7,900) |
| Profit for the period | - | - | - | - | - | (1,073) | (1,073) | (692) | (1,765) |
| Other comprehensive income/(loss) | - | - | - | - | (623) | - | (623) | 1,017 | 394 |
| Total comprehensive income/(loss) for the period |
- | - | - | - | (623) | (1,073) | (1,696) | 325 | (1,371) |
| Balance as at 31 March 2016 (unaudited) |
150 | 37,366 | (112) | - | (10,239) | (42,624) | (15,459) | 6,188 | (9,271) |
| Attributable to owners of the Company | Non | Total equity | |||||||
| In thousands of US dollars | Share capital |
Share premium |
Treasury shares |
Prepayment for future share issue |
Currency translation reserve |
Retained earnings |
Total attributable to owners of the Company |
controlling interest |
|
| Balance as at 31 December 2014 | 150 | 37,366 | (112) | - | (15,503) | (25,625) | (3,724) | 11,283 | 7,559 |
| Profit for the period | - | - | - | - | - | (8,342) | (8,342) | (1,391) | (9,733) |
| Other comprehensive income/(loss) | - | - | - | - | (280) | - | (280) | (3,269) | (3,549) |
| Total comprehensive income/(loss) for the period |
- | - | - | - | (280) | (8,342) | (8,622) | (4,660) | (13,282) |
| Balance as at 31 March 2015 |
The accompanying notes are an integral part of these interim condensed consolidated financial statements
(unaudited) 150 37,366 (112) - (15,873) (33,976) (12,346) 6,623 (5,723)
KSG Agro S.A. (the "Company") was incorporated under the name Borquest S.A. on 16 November 2010 as a "Société Anonyme" under Luxembourg company law for an unlimited period. On 8 March 2011 the Company's name was changed to KSG Agro S.A.
The registered office of the Company is at 24, rue Astrid, L-1143 Luxembourg and the Company number with the Registre de Commerce is B 156 864.
The Company, its subsidiaries and joint operation (together referred to as the "Group") produces, processes and sells agricultural products and its business activities are conducted mainly in Ukraine.
The number of employees of the Group as at 31 March 2016 was 671 employees (31 December 2015: 623 employees). Scope of consolidation
The Group's parent is OLBIS Investments LTD S.A., (65%) - , registered in Panama and the ultimate controlling party is Mr. Sergiy Kasianov. Remain Group's shares (35%) listed on the Warsaw Stock Exchange.
The subsidiaries and principal activities of the companies forming the Group and the Parent's effective ownership interest as at 31 March 2016 and 31 December 2015 were as follows:
| Effective ownership ratio, % | ||||
|---|---|---|---|---|
| Operating entity | Principal activity | Country of registration |
31 March 2016 | 31 December 2015 |
| KSG Agro S.A. | Holding company | Luxembourg | Parent | Parent |
| KSG Agricultural and Industrial Holding LTD |
Subholding company | Cyprus | 100% | 100% |
| KSG Agro Polska | Trade of agricultural products |
Poland | 100% | 100% |
| KSG Energy Group LTD | Trade of pellets | Cyprus | 50% | 50% |
| Parisifia LTD | Intermediate holding company |
Cyprus | 50% | 50% |
| Abbondanza SA | Trade of agricultural products |
Switzerland | 50% | 50% |
| Enterprise №2 of Ukrainian agricultural and industrial holding LLC |
Agricultural production | Ukraine | 100% | 100% |
| Scorpio Agro LLC | Agricultural production | Ukraine | 100% | 100% |
| Goncharovo Agricultural LLC | Agricultural production | Ukraine | 100% | 100% |
| Agro-Trade House Dniprovsky LLC |
Agricultural production | Ukraine | 100% | 100% |
| Dnipro LLC | Agricultural production | Ukraine | 100% | 100% |
| KSG Trade House LTD | Trade of agricultural products |
Ukraine | 100% | 100% |
| Trade House of the Ukrainian Agroindustrial Holding LLC |
Agricultural production | Ukraine | 100% | 100% |
| Askoninteks LLC | Agricultural production | Ukraine | 100% | 100% |
| Agro Golden LLC | Agricultural production | Ukraine | 100% | 100% |
| Agro LLC | Lessor of equipment | Ukraine | 100% | 100% |
| SPE Promvok LLC | Lessor of equipment | Ukraine | 100% | 100% |
| Dniproagroprogress LLC ** | Agricultural production | Ukraine | 0.1% | 0.1% |
| Meat plant Dnipro LLC | Manufacture | Ukraine | 100% | 100% |
| Hlebna Liga LLC | Trader | Ukraine | 100% | 100% |
| Agrofirm Vesna LLC | Agricultural production | Ukraine | 100% | 100% |
| Agrotrade LLC | Agricultural production | Ukraine | 50% | 50% |
| Factor D LLC | Agricultural production | Ukraine | 50% | 50% |
| Rantye LLC | Agricultural production | Ukraine | 50% | 50% |
| PrJSC Pererobnyk | Flour and animals' feed producing |
Ukraine | 25% | 25% |
| Agroplaza LLC | Intermediate holding company |
Ukraine | 50% | 50% |
| Stepove LLC | Agricultural production | Ukraine | 50% | 50% |
| Effective ownership ratio, % | ||||
|---|---|---|---|---|
| Operating entity | Principal activity | Country of registration |
31 March 2016 | 31 December 2015 |
| Dzherelo LLC | Agricultural production | Ukraine | 50% | 50% |
| Kolosyste LLC | Agricultural production | Ukraine | 50% | 50% |
| Hlebodar LLC * | Agricultural production | Ukraine | 50% | 50% |
| Ukrzernoprom - Prudy LLC * | Agricultural production | Ukraine | 50% | 50% |
| Ukrzernoprom - Uyutne LLC * | Agricultural production | Ukraine | 50% | 50% |
| Ukrzernoprom - Kirovske LLC * | Agricultural production | Ukraine | 50% | 50% |
| Ukrzernoprom - Yelizavetove LLC * | Agricultural production | Ukraine | 50% | 50% |
| KSG Dnipro LLC (SFG Bulah LLC) | Agricultural production | Ukraine | 100% | 100% |
| Ranniy Ranok LLC | Agricultural production | Ukraine | 100% | 100% |
| Pererobnyk LLC PE | Flour and animals' feed producing |
Ukraine | 25% | 25% |
Companies marked with * are located in Crimea. The Group has no operating control over them starting from October 01, 2014, so deconsolidation of these companies was provided and net assets were written off to zero.
On the annual basis companies with voting rights less than 51% tests for the compliance with IFRS 10 regarding existence of control. In these consolidated financial statements presented subsidiaries with absolute control over operating activity and cash flows and total responsibilities for the incurred profits or losses.
Company marked with ** are de-consolidated due to the fact of control transfer to third parties.
These consolidated financial statements are presented in thousand US dollars ("USD"), unless otherwise stated.
Basis of preparation. These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpritations of IFRS issured by International Financial Reporting Interpretations Committee ("IFRIC") and as adopted by the European Union. These consolidated financial statements have been prepared under the historical cost convention, as modified by the initial recognition of a share purchase warrant at fair value and the recognition of biological assets and agricultural produce based on fair value less costs to sell.
Going concern assumption. The accompanying consolidated financial statements have been prepared assuming that the Group will continue as a going concern, which assumes continuity of operations and realization of assets and satisfaction of liabilities in the ordinary course of business.
The main assumptions used for the budget have been estimated by the management of the Group, based on their knowledge of their local market at a date near the approval of the consolidated financial statements. The Group management assumptions are based on following judgements:
The Group incurred a total comprehensive loss of USD (1,371) thousand during the year ended March 31, 2016 and as of that date current liabilities of the Group exceeded its current assets by USD 11,513 thousand. The Group has negative net equity of USD (9,271) thousand as at March 31, 2016. This gives rise to a material uncertainty related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business.
Operating companies of KSG Agro S.A. have accumulated losses to date, significant new business opportunities have arisen. In particular, these opportunities have arisen in pigs breeding segment. The management has included these new business opportunities within their scenario based forecasts and on this basis the management believes there is a reasonable expectation that the Group will continue in operational existence for the foreseeable future. Accordingly, the management continues to adopt the going concern basis in preparing the financial statements.
Consolidated financial statements. Group recognise controls on subsidiary if next criteria are met:
power over the investee;
exposure, or rights, to variable returns from its involvement with the investee;
the ability to use its power over the investee to affect the amount of the Group's returns.
Subsidiaries are consolidated from the date on which control is transferred to the Group (acquisition date) and are deconsolidated from the date on which control ceases.
The acquisition method of accounting is used to account for the acquisition of subsidiaries. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured at their fair values at the acquisition date, irrespective of the extent of any non-controlling interest.
The Group measures non-controlling interest that represents present ownership interest and entitles the holder to a proportionate share of net assets in the event of liquidation on a transaction by transaction basis, either at: (a) fair value, or (b) the non-controlling interest's proportionate share of net assets of the acquiree. Non-controlling interests that are not present ownership interests are measured at fair value.
Goodwill is measured by deducting the net assets of the acquiree from the aggregate of the consideration transferred for the acquiree, the amount of non-controlling interest in the acquiree and the fair value of an interest in the acquiree held immediately before the acquisition date. Any negative amount ("negative goodwill") is recognised in profit or loss after management reassesses whether it identified all the assets acquired and all liabilities and contingent liabilities assumed and reviews the appropriateness of their measurement.
The consideration transferred for the acquiree is measured at the fair value of the assets given up, equity instruments issued and liabilities incurred or assumed, including fair value of assets or liabilities from contingent consideration arrangements but excludes acquisition related costs such as advisory, legal, valuation and similar professional services. Transaction costs related to the acquisition and incurred for issuing equity instruments are deducted from equity and all other transaction costs associated with the acquisition are expensed.
Intercompany transactions, balances and unrealised gains on transactions between Group subsidiaries are eliminated. Unrealised losses are also eliminated unless the cost cannot be recovered. The Company and all of its subsidiaries use uniform accounting policies consistent with the Group's policies.
Non-controlling interest is that part of the net results and of the equity of a subsidiary attributable to interests which are not owned, directly or indirectly, by the Group. Non-controlling interest is recorded as a separate component of the Group's equity.
Goodwill. Goodwill on acquisitions of subsidiaries is presented within intangible assets in the consolidated statement of financial position. It is carried at cost less accumulated impairment, if any. The Group tests goodwill for impairment at least annually and whenever there are indications that goodwill may be impaired. Goodwill is allocated to cashgenerating units for the purpose of impairment testing. The allocation is made to those cash-generating units or groups of cash-generating units that are expected to benefit from the business from which the goodwill arose. Such units or groups of units represent the lowest level at which the Group monitors goodwill and are not larger than an operating segment.
Joint operations. The Group accounts for the interest in the joint operations to the extent of:
Depending on their classification financial instruments are carried at fair value or amortised cost as described below.
Fair value is price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
Valuation techniques such as discounted cash flow models or models based on recent arm's length transactions or consideration of financial data of the investees are used to measure at fair value certain financial instruments for which external market pricing information is not available. Valuation techniques may require assumptions not supported by observable market data. Disclosures are made in these financial statements if changing any such assumptions to a reasonably possible alternative would result in significantly different profit, income, total assets or total liabilities.
Transaction costs are incremental costs that are directly attributable to the acquisition, issue or disposal of a financial instrument. An incremental cost is one that would not have been incurred if the transaction had not taken place.
Transaction costs include fees and commissions paid to agents (including employees acting as selling agents), advisors, brokers and dealers, levies by regulatory agencies and securities exchanges, and transfer taxes and duties. Transaction
costs do not include debt premiums or discounts, financing costs or internal administrative or holding costs.
Amortised cost is the amount at which the financial instrument was recognised at initial recognition less any principal repayments, plus accrued interest, and for financial assets less any write-down for incurred impairment. Accrued interest includes amortisation of transaction costs deferred at initial recognition and of any premium or discount to maturity amount using the effective interest method. Accrued interest income and accrued interest expense, including both accrued coupon and amortised discount or premium (including fees deferred at origination, if any), are not presented separately and are included in the carrying values of related items in the statement of financial position.
The effective interest method is a method of allocating interest income or interest expense over the relevant period, so as to achieve a constant periodic rate of interest (effective interest rate) on the carrying amount. The effective interest rate is the rate that exactly discounts estimated future cash payments or receipts (excluding future credit losses) through the expected life of the financial instrument or a shorter period, if appropriate, to the net carrying amount of the financial instrument. The effective interest rate discounts cash flows of variable interest instruments to the next interest repricing date, except for the premium or discount which reflects the credit spread over the floating rate specified in the instrument, or other variables that are not reset to market rates. Such premiums or discounts are amortised over the whole expected life of the instrument. The present value calculation includes all fees paid or received between parties to the contract that are an integral part of the effective interest rate.
Classification of financial assets. The Group classifies all of its financial assets as loans and receivables. Loans and receivables are unquoted non-derivative financial assets with fixed or determinable payments other than those that the Group intends to sell in the near term. Loans and receivables are accounted for at amortized cost using the effective interest method, net of provision for impairment after their initial evaluation. Loans and receivables that mature more than 12 months after the consolidated statement of financial position date are included into non-current assets. The Group's financial assets are long term receivables, promissory note receivables, term deposits, trade and other accounts receivable, cash and cash equivalents.
Classification of financial liabilities. The Group's financial liabilities include loans, borrowings, trade and other payables, financial lease, promissory notes issued and derivative financial instruments. Financial liabilities are measured subsequently at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL, which are carried subsequently at fair value with gains or losses recognised in profit or loss (other than derivative financial instruments that are designated and effective as hedging instruments).
Loans and borrowings. Borrowings are recognised initially at fair value, net of transaction costs incurred, and are subsequently carried at amortised cost using the effective interest method. Any difference between the proceeds, net of transaction costs, and the redemption value is recognised in profit or loss over the period of the borrowings using the effective interest method. Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least twelve months after the balance sheet date.
Trade and other payables. Trade payables are accrued when the counterparty performs its obligations under the contract and are carried at amortised cost using the effective interest method.
Financial assistance payable. Financial assistance payable is initially recognised at the fair value and carried at amortised cost using the effective interest method. Financial assistance is disclosed within trade and other payables.
Initial recognition of financial instruments. Derivatives are initially recorded at fair value. All other financial instruments are initially recorded at fair value plus transaction costs. Fair value at initial recognition is best evidenced by the transaction price. A gain or loss on initial recognition is only recorded if there is a difference between fair value and transaction price which can be evidenced by other observable current market transactions in the same instrument or by a valuation technique whose inputs include only data from observable markets.
Derecognition of financial assets. The Group derecognises financial assets when (a) the assets are redeemed or the rights to cash flows from the assets otherwise expire or (b) the Group has transferred the rights to the cash flows from the financial assets or entered into a qualifying pass-through arrangement while (i) also transferring substantially all risks and rewards of ownership of the assets or (ii) neither transferring nor retaining substantially all risks and rewards of ownership but not retaining control. Control is retained if the counterparty does not have the practical ability to sell the asset in its entirety to an unrelated third party without needing to impose additional restrictions on the sale.
Land lease rights. Land lease rights acquired in business combinations are initially recognised at their fair value and subsequently are carried at cost less accumulated amortisation and impairment. When agreements on the right to lease land are renegotiated, the Group capitalises incurred costs relating to the agreement prolongation and revises useful lives of land lease rights based on the prolonged term. Recognized on consolidation lease agreements are amortized on straight line method over the term of the agreements without considering possible prolongation.
Property, plant and equipment. Property, plant and equipment items are stated at cost less accumulated depreciation and, where applicable, accumulated impairment. Such cost includes the cost of replacing part of the property, plant and
equipment and borrowing costs for long-term construction projects, if the recognition criteria are met. All repair and maintenance costs are expensed as incurred. An item of property, plant and equipment and any significant part initially recognised is derecognised upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in profit or loss when the asset is derecognised. The assets residual values, useful lives and methods of depreciation are reviewed at each financial year end and adjusted prospectively, if appropriate.
Construction-in-progress represents the cost of properties, plant and equipment which have not yet been completed less any accumulated impairment. This includes cost of construction works, cost of plant and equipment and other direct costs.
The Group leases the land on which its operations are located under operating lease agreements and therefore land is not included in the consolidated financial statements.
At each end of each reporting period management assesses whether there is any indication of impairment of property, plant and equipment. If any such indication exists, management estimates the recoverable amount, which is determined as the higher of an asset's fair value less costs to sell and its value in use. The carrying amount is reduced to the recoverable amount and the impairment is recognised in profit or loss. An impairment recognised for an asset in prior years is reversed where appropriate if there has been a change in the estimates used to determine the asset's value in use or fair value less costs to sell. Gains and losses on disposals are determined by comparing proceeds with the carrying amount and are recognised in profit or loss.
Depreciation. Depreciation of property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives:
| Useful lives in years | |
|---|---|
| Buildings and structures | 5-30 |
| Agricultural equipment | 3-15 |
| Vehicles and office equipment | 3-17 |
The residual value of an asset is the estimated amount that the Group would currently obtain from disposal of the asset less the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
Operating leases. Where the Group is a lessee in a lease which does not transfer substantially all the risks and rewards incidental to ownership from the lessor to the Group, the total lease payments are charged to profit or loss on a straightline basis over the lease term. The lease term is the non-cancellable period for which the lessee has contracted to lease the asset together with any further terms for which the lessee has the option to continue to lease the asset, with or without further payment, when at the inception of the lease it is reasonably certain that the lessee will exercise the option.
Income taxes. The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the balance sheet date in the countries where the Group's subsidiaries operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities. The income tax charge comprises current tax and deferred tax and is recognised in profit or loss for the year, except if it is recognised in other comprehensive income or directly in equity because it relates to transactions that are also recognised, in the same or a different period, in other comprehensive income or directly in equity.
Current tax is the amount expected to be paid to, or recovered from, the taxation authorities in respect of taxable profits or losses for the current and prior periods. Taxes other than on income are recorded within operating expenses.
Deferred income tax is provided using the balance sheet liability method for tax loss carry forwards and temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. In accordance with the initial recognition exemption, deferred taxes are not recorded for temporary differences on initial recognition of an asset or a liability in a transaction other than a business combination if the transaction, when initially recorded, affects neither accounting nor taxable profit. Deferred tax liabilities are not recorded for temporary differences on initial recognition of goodwill, and subsequently for goodwill which is not deductible for tax purposes. Deferred tax balances are measured at tax rates enacted or substantively enacted at the end of the reporting period, which are expected to apply to the period when the temporary differences will reverse or the tax loss carry forwards will be utilised. Deferred tax assets and liabilities are netted only within the individual companies of the Group. Deferred tax assets for deductible temporary differences and tax loss carry forwards are recorded only to the extent that it is probable that future taxable profit will be available against which the deductions can be utilised.
Special tax for agricultural producers. The Company's subsidiaries in Ukraine engaged in the production, processing and sale of agricultural products may opt for paying a special tax for agricultural producers ("Group #4 of Tax payers
defined in Tax Code of Ukraine") in lieu of corporate income tax, land tax, duties for special use of water objects, municipal tax, vehicle tax, duties for geological survey works and duties for trade patents if the revenues from sale of their self-grown agricultural products constitute not less than 75% of their total gross revenues. The amount of special tax for agricultural producers is assessed at 0.15% on the deemed value of the land plots owned or leased by the entity (as determined by the relevant State authorities). 31 March 2016, 4 Ukrainian subsidiaries of the Group elected to pay special tax (31 December 2015: 4). The rest of the Group's entities are subject to regular income tax.
Value added tax. In Ukraine VAT is levied at two rates: 20% on sales and imports of goods within the country, works and services and 0% on the export of goods and provision of works or services to be used outside Ukraine. Output VAT on the sale of goods and services is accounted for on the date the goods/services are delivered to a customer or the date the payment is received from the customer, whichever is earlier. Input VAT is accounted for as follows: entitlement to an input tax credit for purchases arises when VAT invoice is received which is issued on the earlier of the date of payment to the supplier or the date, on which the goods/services are received or entitlement to an input tax credit for imported goods or services arises on the date the tax is paid.
VAT related to sales and purchases is recognised in the statement of financial position on a net basis and disclosed as an asset or liability to the extent it has been recorded in VAT declarations. Prepayments issued and prepayments received are disclosed in these consolidated financial statements net of VAT balances as it is expected that such balances will be settled by delivery of the underlying product or service.
The Group's subsidiaries involved in the production and sale of agricultural produce and that meet certain other criteria are subject to a privileged VAT regime. For such qualifying entities, the net VAT payable is not transferred to the State authorities, but is retained in the business for use in agricultural production. Such net VAT liabilities are credited to profit and loss as government grants.
Government grants. According to the Ukrainian VAT legislation VAT which agricultural producers charge on sales of agricultural produce, net of VAT paid on purchases, is not transferred to the State budget but can be retained for use in agricultural production. These government grants are recognised in profit or loss for the year once the Group makes the qualifying expenditures on agricultural supplies or equipment.
Biological assets. Biological assets represent crops in the field and livestock and are measured at fair value less costs to sell.
Crops in the field. The fair value of crops in the field is determined by using valuation techniques, as there is no market for winter crops and other long-term crops of the same physical condition. The fair value of the Group's biological assets is calculated as the present value of anticipated future cash flows from the asset before tax. The fair value calculation of crops in the field is based on the existing field under crops and the assessments regarding expected crop yield on harvest, time of harvest, future cultivation, treatment, harvest costs and selling prices. The discount rate is determined by reference to weighted-average cost capital based on risk profile of the Group.
Livestock. The fair value of non-current livestock is determined by using valuation techniques, as there is no market for sows of the same physical conditions, such as weight, age and breed. The fair value of livestock is based on expected litter of piglets, expected volume of meat at the date of slaughter, respective anticipated prices, average expected productive lives of the livestock and future production costs. The discount rate is determined by reference to current market determined pre-tax rate.
A gain or loss arising on initial recognition of a biological asset at the fair value less costs to sell and from a change in the fair value less costs to sell of a biological asset at each subsequent reporting date is included in income statement in the period in which it arises.
The biological assets are classified as current or non-current depending on the expected pattern of consumption of the economic benefits embodied in the biological assets. Dairy cattle, sows, fruit gardens and long-term grass are classified as non-current and livestock husbandry and winter crops are classified as current biological assets.
Cost of agricultural preparation of fields before seeding is recorded as work-in-progress in inventories. After seeding the cost of field preparation is reclassified to biological assets held at fair value.
Agricultural produce. Agricultural produce harvested from the Group's biological assets is measured at its fair value less estimated costs to sell at the date of harvest.
Inventories. Inventories are recorded at the lower of cost and net realisable value. Cost of inventory is determined on the first in first out basis. The cost of work in progress comprises fuel and other raw material, direct labour, depreciation and amortization, other direct costs and related production overheads (based on normal operating capacity) but excludes borrowing costs. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated cost of completion and selling expenses.
Trade and other receivables. Trade and other receivables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest method, less provision for impairment.
Advances issued. Advances issued to suppliers are carried at cost less provision for impairment. An advance issued is classified as non-current when the goods or services relating to the prepayment are expected to be obtained after one year, or when the advance relates to an asset which will itself be classified as non-current upon initial recognition. Advances issued to acquire assets are transferred to the carrying amount of the asset once the Group has obtained control of the asset and it is probable that future economic benefits associated with the asset will flow to the Group. Other advances are written off to profit or loss when the services relating to the advances are received. If there is an indication that the assets or services relating to an advance will not be received, the carrying value of the advance is written down accordingly and a corresponding impairment is recognised in profit or loss.
Impairment of financial assets carried at amortised cost. Impairment are recognised in profit or loss when incurred as a result of one or more events ("loss events") that occurred after the initial recognition of the financial asset and which have an impact on the amount or timing of the estimated future cash flows of the financial asset or group of financial assets that can be reliably estimated. If the Group determines that no objective evidence exists that impairment was incurred for an individually assessed financial asset, whether significant or not, it includes the asset in a group of financial assets with similar credit risk characteristics, and collectively assesses them for impairment. The primary factors that the Group considers in determining whether a financial asset is impaired are its overdue status and realisability of related collateral, if any. The following other principal criteria are also used to determine whether there is objective evidence that an impairment has occurred:
If the terms of an impaired financial asset held at amortised cost are renegotiated or otherwise modified because of financial difficulties of the counterparty, impairment is measured using the original effective interest rate before the modification of terms.
Impairment are always recognised through an allowance account to write down the asset's carrying amount to the present value of expected cash flows (which exclude future credit losses that have not been incurred) discounted at the original effective interest rate of the asset. The calculation of the present value of the estimated future cash flows of a collateralised financial asset reflects the cash flows that may result from foreclosure less costs for obtaining and selling the collateral, whether or not foreclosure is probable.
Uncollectible assets are written off against the related impairment provision after all the necessary procedures to recover the asset have been completed and the amount of the loss has been determined. Subsequent recoveries of amounts previously written off are credited to impairment account within the profit or loss for the year.
Cash and cash equivalents. Cash and cash equivalents includes cash on hand, deposits held at call with banks, and other short-term, highly liquid investments with original maturities of three months or less. For the purpose of the consolidated cash flow statement, cash and cash equivalents consist of cash as defined above, net of outstanding bank overdrafts, if any.
Share capital. Ordinary shares are classified as equity. Share premium is the difference between the fair value of the consideration received for the issue of shares and the nominal value of the shares. The share premium account can only be used for limited purposes, which do not include the distribution of dividends, and is otherwise subject to the provisions of the legislation in Luxembourg on reduction of share capital.
Borrowing costs. General and specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.
All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
Provisions for liabilities and charges. Provisions for liabilities and charges are non-financial liabilities of uncertain timing or amount. They are accrued when the Group has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.
Employee benefits - defined contribution plan. The Group makes statutory unified social contribution to the Pension Fund of Ukraine in respect of its Ukrainian based employees. The contributions are calculated as a percentage of current gross salary and are expensed when incurred.
Wages, salaries, unified social contribution to Pension Fund of Ukraine, paid annual leave and sick leave, bonuses are accrued in the year in which the associated services are rendered by the employees of the Group.
Functional and presentation currency. The currency of each consolidated entity is the currency of the primary economic environment in which the entity operates. The functional currency for the majority of the consolidated entities is the Ukrainian hryvnia. As the Group's management uses USD when monitoring operating results and financial conditions of the Group, the presentation currency of the financial statements is USD. All information in USD has been rounded to the nearest thousand, except when otherwise indicated. The results and financial position of all the group entities (none of which has the currency of a hyper-inflationary economy) that have a functional currency different from the presentation currency are translated into the presentation currency as follows:
Transactions denominated in currencies other than the relevant functional currency are translated into the functional currency using the exchange rate prevailing at the date of the transaction. Foreign exchange gains and losses resulting from settlement of such transactions and from the translation of foreign currency denominated monetary assets and liabilities at year end, are recognized in profit or loss. Translation at year end does not apply to nonmonetary items.
When control over a foreign operation is lost, the previously recognised exchange differences on translation to a different presentation currency are reclassified from other comprehensive income to profit or loss for the year as part of the gain or loss on disposal. On partial disposal of a subsidiary without loss of control, the related portion of accumulated currency translation differences is reclassified to non-controlling interest within equity.
Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and translated at the closing rate.
The exchange rates used for translating foreign currency balances were:
| 31 March 2016 | 31 December 2015 | |
|---|---|---|
| USD/UAH | 26.2181 | 24.0007 |
| USD/UAH average for the period | 25.7973 | 21.8123 |
| EUR/UAH | 29.6893 | 26.2231 |
| EUR/UAH average for the period | 28.4538 | 24.1905 |
Revenue recognition. Revenues from sales of goods are recognised at the point of transfer of risks and rewards of ownership of the goods. If the Group agrees to transport goods to a specified location, revenue is recognised when the goods are passed to the customer at the destination point.
Revenues from rendering of services are recognised in the accounting period in which the services are rendered, by reference to stage of completion of the specific transaction assessed on the basis of the actual service provided as a proportion of the total services to be provided.
Revenues are shown net of Value Added Tax and discounts. Revenues are measured at the fair value of the consideration received or receivable.
Finance income and costs. Finance income and costs mainly comprise interest income and cash on equivalents and bank deposits, interest expense on borrowings and finance leases and exchange differences on borrowings.
Segment reporting. Operating segments are reported in a manner consistent with the internal reporting provided to the Group's chief operating decision maker. Segments whose revenue, result or assets are ten percent or more of all the segments are reported separately.
The Group makes estimates and assumptions that affect the amounts recognised in the consolidated financial statements. Estimates and judgements are continually evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Management
also makes certain judgements, apart from those involving estimations, in the process of applying the Group's accounting policies. Judgements that have the most significant effect on the amounts recognised in the consolidated financial statements and estimates that can cause a significant adjustment to the carrying amount of assets and liabilities within the next year are:
Biological assets. In the absence of observable market prices for biological assets in their condition at the reporting dates, the fair value of biological assets was estimated as the present value of future net cash flows expected to be generated from the assets discounted at a current market-determined pre-tax rate.
Fair values of biological assets are based on the following key assumptions:
The methodology and assumptions used for estimating both the amount and timing of future cash flows are reviewed regularly to reduce any differences between estimates and actual numbers. The key assumptions used to determine the fair value of biological assets presented in Note 11.
Agricultural produce. Agricultural produce is the harvested product of the Group's biological assets. It is recorded at its estimated fair value less costs to sell, at the point of harvest. The determination of fair value for a biological asset or agricultural produce is facilitated by grouping the produce according to significant attributes; for example, by type or quality. The fair value of each group of agricultural produce at the end of the reporting period is determined as lower of the available average market price for similar products at the point of harvest and net realizable value. The methodology and assumptions used for estimating both the amount and timing of future cash flows are reviewed regularly to reduce any differences between estimates and actual numbers. A 10% increase or decrease in market prices compared to the selling prices used would result in an increase or decrease in the fair value of agricultural produce of USD 330 thousand (31 December 2014: USD 1,061 thousand).
Allowance for doubtful receivables. The Group periodically assesses recoverability of receivables from main debtors. In the case objective evidence of uncollectability is in place, allowance is provided for the amount of doubtful receivables. No allowance for receivables from related parties is charged. Additionally a general provision for doubtful debts is provided on all receivables due for more than 365 days.
Cost of inventories. At each reporting date the Group carries out assessment of goods for signs impairment of initial value. As at March 31, 2016 the Group's management uses method of individual assessment of each unit of goods. The same approach was used in 2014.
Goodwill. Goodwill arising from the acquisition of subsidiaries is tested for impairment annually as at 31 December and when circumstances indicate that the carrying value may be impaired. Impairment is determined for goodwill by assessing the recoverable amount (estimated under five-year cash flows financial plans) of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment is recognised. Impairment relating to goodwill cannot be reversed in the future periods.
Useful lives. Management estimates are necessary to identify the useful lives of property, plant and equipment. Management uses its expertise and judgment in reassessing the remaining useful lives of major items at each reporting date.
Subsidiaries. The Group consolidates the result of Parisifia Trading Ltd (Cyprus), KSG Energy Group Ltd (Cyprus) and Abondanza S.A. (Switzerland) although it only holds 50% of the voting rights, because it has the power to govern its financial and operating policies through arrangements with the other 50% shareholder. The Group also consolidates the results of Pererobnyk PrJSC, a company in which it holds 25% of the voting rights, because it has the power to govern its financial and operating policies through its sole presence in the supervisory and management boards of the company and ability to determine remuneration of its representatives in these governance bodies. Majority of the supervisory and management board members are employees of other entities of the Group. Judgement is required to determine whether the substance of the relationship between the Group and a subsidiary indicates that the entity is controlled by the Group. In making this judgement management considered arrangements with the other shareholders of the subsidiary.
Fair value measurement. Management uses valuation techniques to determine the fair value of financial instruments (where active market quotes are not available – Note 16) and non-financial assets (Note 9, 11). This involves developing estimates and assumptions consistent with how market participants would price the instrument. Management bases its assumptions on observable data as far as possible but this is not always available. In that case management uses the best information available. Estimated fair values may vary from the actual prices that would be achieved in an arm's length transaction at the reporting date
Income tax and deferred taxes The Group is subject to income taxes in numerous jurisdictions. Significant estimates are required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain. The Group recognises liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the current tax and deferred tax provisions.
Deferred tax assets are recognized for all unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and level of future taxable profits together with future tax planning strategies.
No business acquisitions or disposals took place during three months ended 31 March 2016.
Movement of property, plant and equipment for the three months ended 31 March 2016 and 2015 was as follows:
| In thousands of US dollars | Buildings and construction |
Agricultural equipment |
Vehicles and office equipment |
Construction in progress |
Total |
|---|---|---|---|---|---|
| Carrying amount as at 1 January 2016 (unaudited) |
11,052 | 2,270 | 418 | 8,760 | 22,500 |
| Additions | 132 | 37 | 21 | 494 | 684 |
| Disposals | - | - | - | - | - |
| Transfers | - | - | - | - | - |
| Depreciation charge | (182) | (120) | (33) | - | (335) |
| Exchange differences | (934) | (190) | (38) | (748) | (1,910) |
| Carrying amount as at 31 March 2016 (unaudited) |
10,068 | 1,997 | 368 | 8,506 | 20,939 |
| In thousands of US dollars | Buildings and construction |
Agricultural equipment |
Vehicles and office equipment |
Construct ion in progress |
Total |
|---|---|---|---|---|---|
| Carrying amount as at 1 January 2015 |
21,159 | 7,890 | 3,334 | 7,871 | 40,254 |
| Additions | - | - | - | 1,645 | 1,645 |
| Disposals | (71) | (178) | (3) | (956) | (1,208) |
| Transfers | - | - | 302 | (302) | - |
| Depreciation charge | (270) | (259) | (153) | - | (682) |
| Exchange differences | (6,890) | (2,535) | (1,107) | (2,619) | (13,151) |
| Carrying amount as at 31 March 2015 (unaudited) |
13,928 | 4,918 | 2,373 | 5,639 | 26,858 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Goodwill Land lease rights Other intangible assets |
308 177 - |
336 234 - |
| Total intangible assets | 485 | 570 |
Movements in the carrying amount of land lease rights were as follows:
| 2016 | 2015 | |
|---|---|---|
| In thousands of US dollars | (unaudited) | (unaudited) |
| At 1 January | ||
| Cost | 2,357 | 5,139 |
| Accumulated amortisation | (2,123) | (2,440) |
| Carrying amount as at 1 January | 234 | 2,699 |
| Acquisition / (Disposal) | - | - |
| Effect of de-consolidation | - | - |
| Amortization charge | (37) | (350) |
| Exchange difference, cost | (199) | - |
| Exchange difference, amortisation | 179 | (845) |
| At as at 31 March | 177 | 1,504 |
| Cost | 2,158 | 4,294 |
| Accumulated amortisation | (1,981) | (2,790) |
| Carrying amount as at 31 March | 177 | 1,504 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Raw materials | 91 | 985 |
| Agricultural produce | 1,430 | 930 |
| Agricultural stock | 420 | 660 |
| Work in progress | 696 | 430 |
| Semi-finished goods | 280 | 293 |
| Goods for resale | 120 | 184 |
| Finished goods | - | 154 |
| Fuel | 62 | - |
| Other | 434 | 123 |
| Total inventories and agricultural produce | 3,533 | 3,759 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Crops in the field Livestock husbandry |
2,079 2,244 |
1,911 2,207 |
| Total current biological assets | 4,323 | 4,118 |
The balances of crops in the field were as follows:
| In thousands of US dollars | 31 March 2016 (unaudited), book value |
Hectares as at 31 March 2016 |
31 December 2015, book value |
Hectares as at 31 December 2015 |
|---|---|---|---|---|
| Coleseed (rape) | 244 | 842 | 258 | 842 |
| Wheat | 1,554 | 6,644 | 1,411 | 6,644 |
| Barley | 281 | 2,664 | 242 | 2,664 |
| sunflower | - | - | - | - |
| corn | - | - | - | - |
| Total crops in the field | 2,079 | 10,150 | 1,911 | 10,150 |
Movements in crops in the field during the period consist of:
| In thousands of US dollars | 2016 (unaudited) |
2015 (unaudited) |
|---|---|---|
| Carrying amount as at 1 January | 1,911 | 3,407 |
| Purchases | - | - |
| Investments into future crops and livestock | 396 | 811 |
| Sales | - | |
| Gain/(loss) arising from changes in fair value attributable to physical changes | ||
| and changes in market prices | (34) | (412) |
| Harvested during the period | ||
| Disposals of subsidiaries | ||
| Loss from dead crops | (6) | |
| Exchange differences | (1,474) | |
| (188) | ||
| Carrying amount as at 31 March | 2,079 | 2,332 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Trade accounts receivable (Short term) | 5,424 | 6,763 |
| Less: provision for trade accounts receivable Loans issued |
(2,916) 2,408 |
(579) 2,396 |
| Less: provision for loans issued | (1,005) | (279) |
| Other financial receivables Less: provision for financial receivables |
2,535 (114) |
2,965 (1,731) |
| Total financial trade and other receivables | 6,332 | 9,535 |
| Advances issued | 651 | 1,490 |
| Less: provision for advances issued | (271) | (73) |
| Total trade and other accounts receivable | 6,712 | 10,952 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Long-term Financial lease liabilities |
128 | 128 |
| Bank loans Total long-term loans and borrowings |
37,188 37,316 |
39,358 39,486 |
| Current Financial lease liabilities Bank loans Other loans |
554 8,412 - |
606 3,269 3,513 |
| Total current loans and borrowings | 8,966 | 7,388 |
As at 31 March 2016 the Group's loans and borrowings consisted from the following categories:
| In thousands of US dollars | 31 March 2016 (unaudited) |
|---|---|
| Bank loans | 25,276 |
| Loan from related party | 12,483 |
| Interest payable | 4,625 |
| Accrued provision (reserve) for contingent liabilities | 3,216 |
| Financial lease liabilities | 682 |
| Total bank and other loans | 46,282 |
The carrying value of the Groups' assets pledged as collateral for the Group's bank loans is as follows:
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Property, plant and equipment | 6,308 | 6,308 |
| Receivables (Property rights under agreements on agricultural | ||
| produce selling) | 6,490 | 6,490 |
| Term deposit | 1,738 | 1,738 |
| Inventory | 490 | 490 |
| Biological assets | 1,326 | 1,326 |
| Share in subsidiaries (Property rights) | 1,755 | 1,755 |
| Total carrying amount of collateral | 18,107 | 18,107 |
| In thousands of US dollars | 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|---|---|---|
| Trade payables | 6,916 | 7,572 |
| Payables for own promissory notes | - | - |
| Financial assistance received | 8,072 | 10,912 |
| Land lease payables | 178 | 232 |
| Promissory notes issued to GEM | - | 58 |
| Other accounts payable | 66 | 908 |
| Total financial trade and other payables | 15,232 | 19,682 |
| Prepayments received | 2,476 | 2,835 |
| Litigation reserve | 233 | 254 |
| Wage and salaries accrued | 74 | 93 |
| Total trade and other payables | 18,015 | 22,864 |
| Three months ended 31 March | ||
|---|---|---|
| 2016 | 2015 | |
| In thousands of US dollars | (unaudited) | (unaudited) |
| Sale of agricultural produce and processed food | 4,664 | 1,928 |
| Rendering of services | (6) | 502 |
| Total revenue | 4,658 | 2,430 |
| Three months ended 31 March | ||
|---|---|---|
| 2016 | 2015 | |
| In thousands of US dollars | (unaudited) | (unaudited) |
| Cost of goods sold | 3,601 | 2,171 |
| Cost of services rendered | - | 499 |
| Total cost of sales | 3,601 | 2,670 |
Cost of goods sold for the 3 months ended 31 March 2016 contains of the following components:
| In thousands of US dollars | 31 March 2016 (unaudited) |
|---|---|
| Incurred costs* | 3,675 |
| Revaluation effects | (74) |
| Total cost of sales | 3,601 |
* Incurred costs contains Additional depreciation & amortization 12 thousand US dollars
| Three months ended 31 March | |||
|---|---|---|---|
| In thousands of US dollars | 2016 (unaudited) |
2015 (unaudited) |
|
| Informational, expert and consulting services | 20 | 99 | |
| Transport services | - | 31 | |
| Crops storage and refining | - | - | |
| Wages and salaries | 18 | 55 | |
| Depreciation | 13 | 60 | |
| Bank services | 2 | 35 | |
| Materials | 8 | - | |
| Taxes, other than income tax | 25 | 9 | |
| Other expenses | 39 | 44 | |
| Total selling, general and administrative expenses | 125 | 333 |
| Three months ended 31 March | |||
|---|---|---|---|
| 2016 | 2015 | ||
| In thousands of US dollars | (unaudited) | (unaudited) | |
| Gain/(Loss) on disposal of property, plant , equipment and other current | |||
| assets | - | - | |
| Gain of PPE sale | - | 454 | |
| Maintenance and repairs | - | - | |
| Income from de-consolidation | - | - | |
| Income from equity method accounting of de-consolidated subsidiaries | - | - | |
| Gain on sale of other current assets | - | - | |
| Penalties and fines | - | (134) | |
| Impairment of value-added tax receivable | - | (43) | |
| Impairment of accounts receivable | - | (48) | |
| Write-off of damaged goods | - | (98) | |
| Gain/(Loss) on disposal of subsidiary | - | - | |
| Loss from dead crops | - | - | |
| Other income /(expenses), net | (208) | (29) | |
| Total other income/(expenses),net | (208) | 102 |
| Three months ended 31 March | ||||
|---|---|---|---|---|
| 2016 | 2016 | |||
| In thousands of US dollars | (unaudited) | (unaudited) | ||
| Finance income | ||||
| Interest income | 222 | 86 | ||
| Foreign exchange gain | - | - | ||
| Other finance income | - | 327 | ||
| Total finance income | 222 | 413 | ||
| Finance expenses | ||||
| Interest expense on bank loans | (1,072) | (1,113) |
| Foreign exchange loss | - | - |
|---|---|---|
| Unwinding of discount on long-term financial liabilities | - | - |
| Other finance expenses | (13) | (9) |
| Total finance expenses | (1,085) | (1,122) |
| In thousands of US dollars | 31 March 2016 (unaudited) |
|---|---|
| Foreign exchange gain Foreign exchange loss |
589 (2,423) |
| Total foreign exchange impact | (1,834) |
The Group has four reportable segments, as described below, which are the Group's strategic divisions. The strategic divisions offer different products and services, and are managed separately because they require different technology and marketing strategies. For each of the strategic divisions, the Group's CEO reviews internal management reports on at least quarterly basis. The operations in each of the Group's reporting segments are:
Performance is measured based on segment profit or loss, as included in the internal management reports that are reviewed by the Group's CEO. Segment profit or loss is used to measure performance as management believes that such information is the most relevant in evaluating the results of the Group's segments relative to other entities that operate within these industries.
Group's assets and liabilities are not monitored by operating segments. Substantially all non-current assets relate to subsidiaries located in Ukraine.
Information about operating segments for the three months ended 31 March 2016 is as follows:
| In thousands of US dollars | Crop production |
Food Processing |
Livestock breeding |
Other operations |
Total |
|---|---|---|---|---|---|
| Revenue | 2,573 | 834 | 1,760 | 185 | 5,352 |
| Inter-segment transactions | 87 | (36) | (694) | (51) | (694) |
| Revenue from external | |||||
| customers | 2,660 | 798 | 1,066 | 134 | 4,658 |
| Change in fair value of biological assets less estimated point-of |
|||||
| sale costs | (34) | - | 242 | - | 208 |
| Cost of sales | (1,716) | (693) | (1,029) | (163) | (3,601) |
| Segment profit / (loss) | 910 | 105 | 279 | (29) | 1,265 |
|---|---|---|---|---|---|
| Government grant received | - | - | - | - | 2 |
| Selling, general and | |||||
| administrative expenses | - | - | - | - | (125) |
| Other operating income / | |||||
| (expense), net | - | - | - | - | - |
| Profit for the period | - | - | - | - | 1,142 |
| Finance income | - | - | - | - | 222 |
| Finance expenses | - | - | - | - | (1,085) |
| Foreign currency exchange gain/(loss), | |||||
| net | - | - | - | - | (1,834) |
| Other income | - | ||||
| Other expenses | - | - | - | - | (208) |
| Profit before tax | - | - | - | - | (1,763) |
| Income tax expense | - | - | - | - | (2) |
| Profit for the period | - | - | - | - | (1,765) |
Information about operating segments for the three months ended 31 March 2015 is as follows:
| In thousands of US dollars | Crop production |
Food Processing |
Livestock breeding |
Other operations |
Total |
|---|---|---|---|---|---|
| Revenue | 432 | 348 | 2,108 | 685 | 3,573 |
| Inter-segment transactions | (287) | (2) | (412) | (442) | (1,143) |
| Revenue from external | 1,696 | ||||
| customers | 145 | 346 | 243 | 2,430 | |
| Change in fair value of biological | |||||
| assets less estimated point-of-sale | (412) | - | (244) | 188 | (468) |
| costs | |||||
| Cost of sales | (810) | (283) | (1,248) | (329) | (2,670) |
| Segment profit / (loss) | (1,077) | 63 | 204 | 102 | (708) |
| Government grant received | - | - | - | - | 116 |
| Selling, general and administrative | |||||
| expenses | - | - | - | - | (333) |
| Other operating income / (expense), | |||||
| net | - | - | - | - | (57) |
| Profit for the period | - | - | - | - | (982) |
| Finance income | - | - | - | - | 413 |
| Finance expenses | - | - | - | - | (1,122) |
| Foreign currency exchange gain/(loss), | |||||
| net | - | - | - | - | (8,143) |
| Other income | - | - | - | - | 454 |
| Other expenses | - | - | - | - | (352) |
| Profit before tax | - | - | - | - | (9,732) |
| Income tax expense | - | - | - | - | (1) |
| Profit for the period | - | - | - | - | (9,733) |
Crop production segment, due to seasonality and implications of IAS 41, in the first half of the year mainly reflects the sales of carried forward agricultural produce and effect of biological assets revaluation, while during the second half of the year it reflects sales of crops and effect of revaluation of agricultural produce harvested during the year. Also, crop production segment has seasonal requirements for working capital increase during November-May, to undertake land preparation work.
Food processing segment, pigs' breeding as well as other operations segment are not significantly exposed to the seasonal fluctuations.
Significant related party balances outstanding at the reporting dates are.
| 31 March 2016 (unaudited) |
31 December 2015 (unaudited) |
|||
|---|---|---|---|---|
| In thousands of US dollars | Parent | Entities under common control |
Entities under common control |
|
| Assets | ||||
| Trade accounts receivable Other financial receivables Advances issued |
- - - |
2 - - |
- - - |
634 - - |
| Loans issued Liabilities Trade and other accounts payable |
- - |
- 1,009 |
- - - |
- - 2,579 |
| Prepayments received Loans Interest payable |
- 26 3 |
- 12,457 2,281 |
- 10,297 2,332 |
- 2,650 50 |
Except for loans from related parties, transactions with related parties are recorded at the contractual amounts agreed between the parties.
No material subsequent events after the reporting period did not happen.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.